The recurrence of hepatocellular carcinoma, the sixth most common neoplasm and the third
leading cause of cancer-related mortality worldwide, represents an important clinical …

Simple Summary The evaluation of tumor response to anti-cancer therapy is critical in
oncology for the prompt determination of subsequent treatment and follow-up strategies …

Background: We aimed to evaluate the performance of a deep learning (DL)-based
Radiomics strategy designed for analyzing contrast-enhanced ultrasound (CEUS) to not …

The first edition of the guidelines for the use of ultrasound contrast agents was published in
2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected …

Ultrasonography (US) is a major, sustainable hepatocellular carcinoma (HCC) surveillance
method as it provides inexpensive, real-time, and noninvasive detection. Since US findings …

US is a powerful and nearly ubiquitous tool in the practice of interventional radiology. Use of
contrast-enhanced US (CEUS) has gained traction in diagnostic imaging given the recent …

Objective This study aims to determine the risk factors, patterns, and long-term survival
outcomes of late recurrence after radiofrequency ablation (RFA) for hepatocellular …

Hepatocellular carcinoma (HCC) represents primary liver cancer. Because the development
of HCC limits the prognosis as well as the quality of life of the patients, its management …

Image-guided percutaneous ablation techniques are increasingly being used for the
treatment of malignant tumors of the liver and kidney. Contrast enhanced ultrasound (CEUS) …

Objective To define an optimal cutoff time to distinguish early and late recurrence in
hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA), and to …